nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—Carvedilol—VEGFA—colon cancer	0.0105	0.689	CrCbGaD
Ranolazine—Pain in extremity—Vincristine—colon cancer	0.00731	0.00742	CcSEcCtD
Ranolazine—Amnesia—Fluorouracil—colon cancer	0.00726	0.00737	CcSEcCtD
Ranolazine—Lethargy—Fluorouracil—colon cancer	0.00696	0.00707	CcSEcCtD
Ranolazine—Urinary retention—Vincristine—colon cancer	0.00695	0.00706	CcSEcCtD
Ranolazine—Hearing impaired—Capecitabine—colon cancer	0.0069	0.007	CcSEcCtD
Ranolazine—Dehydration—Vincristine—colon cancer	0.0068	0.0069	CcSEcCtD
Ranolazine—Gait disturbance—Capecitabine—colon cancer	0.00673	0.00683	CcSEcCtD
Ranolazine—Coordination abnormal—Capecitabine—colon cancer	0.00669	0.00679	CcSEcCtD
Ranolazine—Blood creatinine increased—Irinotecan—colon cancer	0.00667	0.00677	CcSEcCtD
Ranolazine—Dehydration—Irinotecan—colon cancer	0.00662	0.00672	CcSEcCtD
Ranolazine—Orthostatic hypotension—Irinotecan—colon cancer	0.0065	0.0066	CcSEcCtD
Ranolazine—Cramp muscle—Irinotecan—colon cancer	0.00641	0.00651	CcSEcCtD
Ranolazine—Depressed level of consciousness—Capecitabine—colon cancer	0.00634	0.00644	CcSEcCtD
Ranolazine—Pancreatitis—Irinotecan—colon cancer	0.00603	0.00613	CcSEcCtD
Ranolazine—Pancytopenia—Vincristine—colon cancer	0.006	0.00609	CcSEcCtD
Ranolazine—Dysuria—Vincristine—colon cancer	0.00591	0.006	CcSEcCtD
Ranolazine—Eosinophilia—Fluorouracil—colon cancer	0.00584	0.00593	CcSEcCtD
Ranolazine—Erectile dysfunction—Vincristine—colon cancer	0.00582	0.00591	CcSEcCtD
Ranolazine—Weight decreased—Vincristine—colon cancer	0.00572	0.00581	CcSEcCtD
Ranolazine—Pancytopenia—Fluorouracil—colon cancer	0.0056	0.00568	CcSEcCtD
Ranolazine—Weight decreased—Irinotecan—colon cancer	0.00557	0.00565	CcSEcCtD
Ranolazine—Renal failure—Irinotecan—colon cancer	0.00539	0.00548	CcSEcCtD
Ranolazine—Renal failure acute—Capecitabine—colon cancer	0.00516	0.00524	CcSEcCtD
Ranolazine—Hot flush—Capecitabine—colon cancer	0.00509	0.00517	CcSEcCtD
Ranolazine—Amnesia—Capecitabine—colon cancer	0.00507	0.00515	CcSEcCtD
Ranolazine—Menopausal symptoms—Capecitabine—colon cancer	0.00505	0.00513	CcSEcCtD
Ranolazine—Hallucination—Vincristine—colon cancer	0.00503	0.00511	CcSEcCtD
Ranolazine—Hypoaesthesia—Vincristine—colon cancer	0.00503	0.00511	CcSEcCtD
Ranolazine—Bradycardia—Irinotecan—colon cancer	0.00502	0.00509	CcSEcCtD
Ranolazine—Urinary tract disorder—Vincristine—colon cancer	0.005	0.00507	CcSEcCtD
Ranolazine—Connective tissue disorder—Vincristine—colon cancer	0.00497	0.00505	CcSEcCtD
Ranolazine—Urethral disorder—Vincristine—colon cancer	0.00496	0.00504	CcSEcCtD
Ranolazine—Epistaxis—Fluorouracil—colon cancer	0.00496	0.00503	CcSEcCtD
Ranolazine—Lethargy—Capecitabine—colon cancer	0.00486	0.00494	CcSEcCtD
Ranolazine—Connective tissue disorder—Irinotecan—colon cancer	0.00484	0.00492	CcSEcCtD
Ranolazine—Diplopia—Capecitabine—colon cancer	0.00477	0.00484	CcSEcCtD
Ranolazine—Pain in extremity—Capecitabine—colon cancer	0.00477	0.00484	CcSEcCtD
Ranolazine—Visual impairment—Irinotecan—colon cancer	0.00475	0.00482	CcSEcCtD
Ranolazine—Depressed level of consciousness—Methotrexate—colon cancer	0.00472	0.00479	CcSEcCtD
Ranolazine—Cardiac disorder—Vincristine—colon cancer	0.00469	0.00477	CcSEcCtD
Ranolazine—Hypoaesthesia—Fluorouracil—colon cancer	0.00469	0.00477	CcSEcCtD
Ranolazine—Angiopathy—Vincristine—colon cancer	0.00459	0.00466	CcSEcCtD
Ranolazine—Cardiac disorder—Irinotecan—colon cancer	0.00457	0.00464	CcSEcCtD
Ranolazine—Mediastinal disorder—Vincristine—colon cancer	0.00456	0.00463	CcSEcCtD
Ranolazine—Urinary retention—Capecitabine—colon cancer	0.00453	0.0046	CcSEcCtD
Ranolazine—Angiopathy—Irinotecan—colon cancer	0.00447	0.00454	CcSEcCtD
Ranolazine—Blood creatinine increased—Capecitabine—colon cancer	0.00446	0.00453	CcSEcCtD
Ranolazine—Mediastinal disorder—Irinotecan—colon cancer	0.00444	0.00451	CcSEcCtD
Ranolazine—Dehydration—Capecitabine—colon cancer	0.00443	0.0045	CcSEcCtD
Ranolazine—Mental disorder—Vincristine—colon cancer	0.00443	0.0045	CcSEcCtD
Ranolazine—Arrhythmia—Irinotecan—colon cancer	0.0044	0.00447	CcSEcCtD
Ranolazine—Orthostatic hypotension—Capecitabine—colon cancer	0.00435	0.00442	CcSEcCtD
Ranolazine—Breast disorder—Capecitabine—colon cancer	0.00431	0.00437	CcSEcCtD
Ranolazine—Flatulence—Irinotecan—colon cancer	0.00423	0.00429	CcSEcCtD
Ranolazine—Arrhythmia—Fluorouracil—colon cancer	0.00421	0.00428	CcSEcCtD
Ranolazine—Muscle spasms—Irinotecan—colon cancer	0.00412	0.00419	CcSEcCtD
Ranolazine—Vertigo—Vincristine—colon cancer	0.00396	0.00402	CcSEcCtD
Ranolazine—Abdominal discomfort—Capecitabine—colon cancer	0.00395	0.00401	CcSEcCtD
Ranolazine—Leukopenia—Vincristine—colon cancer	0.00394	0.004	CcSEcCtD
Ranolazine—Pancytopenia—Capecitabine—colon cancer	0.00391	0.00397	CcSEcCtD
Ranolazine—Vision blurred—Fluorouracil—colon cancer	0.00387	0.00393	CcSEcCtD
Ranolazine—Vertigo—Irinotecan—colon cancer	0.00385	0.00391	CcSEcCtD
Ranolazine—Dysuria—Capecitabine—colon cancer	0.00385	0.00391	CcSEcCtD
Ranolazine—Syncope—Irinotecan—colon cancer	0.00385	0.00391	CcSEcCtD
Ranolazine—Renal failure acute—Methotrexate—colon cancer	0.00384	0.0039	CcSEcCtD
Ranolazine—Leukopenia—Irinotecan—colon cancer	0.00384	0.0039	CcSEcCtD
Ranolazine—Loss of consciousness—Irinotecan—colon cancer	0.00377	0.00383	CcSEcCtD
Ranolazine—Visual disturbance—Methotrexate—colon cancer	0.00374	0.0038	CcSEcCtD
Ranolazine—Cough—Irinotecan—colon cancer	0.00374	0.0038	CcSEcCtD
Ranolazine—Weight decreased—Capecitabine—colon cancer	0.00373	0.00378	CcSEcCtD
Ranolazine—Leukopenia—Fluorouracil—colon cancer	0.00368	0.00373	CcSEcCtD
Ranolazine—Lethargy—Methotrexate—colon cancer	0.00362	0.00368	CcSEcCtD
Ranolazine—Renal failure—Capecitabine—colon cancer	0.00361	0.00367	CcSEcCtD
Ranolazine—Confusional state—Irinotecan—colon cancer	0.00353	0.00358	CcSEcCtD
Ranolazine—Nervous system disorder—Vincristine—colon cancer	0.00352	0.00358	CcSEcCtD
Ranolazine—Thrombocytopenia—Vincristine—colon cancer	0.00352	0.00357	CcSEcCtD
Ranolazine—Haematuria—Capecitabine—colon cancer	0.0035	0.00356	CcSEcCtD
Ranolazine—Hyperhidrosis—Vincristine—colon cancer	0.00347	0.00353	CcSEcCtD
Ranolazine—Epistaxis—Capecitabine—colon cancer	0.00346	0.00352	CcSEcCtD
Ranolazine—Shock—Irinotecan—colon cancer	0.00344	0.0035	CcSEcCtD
Ranolazine—Nervous system disorder—Irinotecan—colon cancer	0.00343	0.00349	CcSEcCtD
Ranolazine—Thrombocytopenia—Irinotecan—colon cancer	0.00343	0.00348	CcSEcCtD
Ranolazine—Anorexia—Vincristine—colon cancer	0.00343	0.00348	CcSEcCtD
Ranolazine—Hyperhidrosis—Irinotecan—colon cancer	0.00338	0.00344	CcSEcCtD
Ranolazine—Confusional state—Fluorouracil—colon cancer	0.00338	0.00343	CcSEcCtD
Ranolazine—Hypotension—Vincristine—colon cancer	0.00336	0.00341	CcSEcCtD
Ranolazine—Bradycardia—Capecitabine—colon cancer	0.00336	0.00341	CcSEcCtD
Ranolazine—Anorexia—Irinotecan—colon cancer	0.00334	0.00339	CcSEcCtD
Ranolazine—Nervous system disorder—Fluorouracil—colon cancer	0.00329	0.00334	CcSEcCtD
Ranolazine—Thrombocytopenia—Fluorouracil—colon cancer	0.00328	0.00333	CcSEcCtD
Ranolazine—Hypoaesthesia—Capecitabine—colon cancer	0.00328	0.00333	CcSEcCtD
Ranolazine—Hypotension—Irinotecan—colon cancer	0.00327	0.00332	CcSEcCtD
Ranolazine—Urinary tract disorder—Capecitabine—colon cancer	0.00326	0.00331	CcSEcCtD
Ranolazine—Insomnia—Vincristine—colon cancer	0.00325	0.0033	CcSEcCtD
Ranolazine—Oedema peripheral—Capecitabine—colon cancer	0.00325	0.0033	CcSEcCtD
Ranolazine—Connective tissue disorder—Capecitabine—colon cancer	0.00324	0.00329	CcSEcCtD
Ranolazine—Urethral disorder—Capecitabine—colon cancer	0.00323	0.00328	CcSEcCtD
Ranolazine—Paraesthesia—Vincristine—colon cancer	0.00323	0.00328	CcSEcCtD
Ranolazine—Breast disorder—Methotrexate—colon cancer	0.00321	0.00326	CcSEcCtD
Ranolazine—Anorexia—Fluorouracil—colon cancer	0.0032	0.00324	CcSEcCtD
Ranolazine—Visual impairment—Capecitabine—colon cancer	0.00318	0.00323	CcSEcCtD
Ranolazine—Insomnia—Irinotecan—colon cancer	0.00317	0.00321	CcSEcCtD
Ranolazine—Paraesthesia—Irinotecan—colon cancer	0.00314	0.00319	CcSEcCtD
Ranolazine—Hypotension—Fluorouracil—colon cancer	0.00313	0.00318	CcSEcCtD
Ranolazine—Decreased appetite—Vincristine—colon cancer	0.00312	0.00317	CcSEcCtD
Ranolazine—Dyspnoea—Irinotecan—colon cancer	0.00312	0.00317	CcSEcCtD
Ranolazine—Somnolence—Irinotecan—colon cancer	0.00311	0.00316	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Vincristine—colon cancer	0.0031	0.00315	CcSEcCtD
Ranolazine—Fatigue—Vincristine—colon cancer	0.0031	0.00315	CcSEcCtD
Ranolazine—Eye disorder—Capecitabine—colon cancer	0.00308	0.00313	CcSEcCtD
Ranolazine—Dyspepsia—Irinotecan—colon cancer	0.00308	0.00313	CcSEcCtD
Ranolazine—Tinnitus—Capecitabine—colon cancer	0.00307	0.00312	CcSEcCtD
Ranolazine—Constipation—Vincristine—colon cancer	0.00307	0.00312	CcSEcCtD
Ranolazine—Cardiac disorder—Capecitabine—colon cancer	0.00306	0.00311	CcSEcCtD
Ranolazine—Decreased appetite—Irinotecan—colon cancer	0.00304	0.00309	CcSEcCtD
Ranolazine—Eosinophilia—Methotrexate—colon cancer	0.00304	0.00308	CcSEcCtD
Ranolazine—Insomnia—Fluorouracil—colon cancer	0.00303	0.00308	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00302	0.00307	CcSEcCtD
Ranolazine—Fatigue—Irinotecan—colon cancer	0.00302	0.00306	CcSEcCtD
Ranolazine—Paraesthesia—Fluorouracil—colon cancer	0.00301	0.00306	CcSEcCtD
Ranolazine—Pancreatitis—Methotrexate—colon cancer	0.00301	0.00305	CcSEcCtD
Ranolazine—Constipation—Irinotecan—colon cancer	0.00299	0.00304	CcSEcCtD
Ranolazine—Angiopathy—Capecitabine—colon cancer	0.00299	0.00304	CcSEcCtD
Ranolazine—Dyspnoea—Fluorouracil—colon cancer	0.00299	0.00303	CcSEcCtD
Ranolazine—Somnolence—Fluorouracil—colon cancer	0.00298	0.00303	CcSEcCtD
Ranolazine—Mediastinal disorder—Capecitabine—colon cancer	0.00297	0.00302	CcSEcCtD
Ranolazine—Dyspepsia—Fluorouracil—colon cancer	0.00295	0.003	CcSEcCtD
Ranolazine—Arrhythmia—Capecitabine—colon cancer	0.00295	0.00299	CcSEcCtD
Ranolazine—Abdominal discomfort—Methotrexate—colon cancer	0.00294	0.00299	CcSEcCtD
Ranolazine—Gastrointestinal pain—Vincristine—colon cancer	0.00294	0.00298	CcSEcCtD
Ranolazine—Decreased appetite—Fluorouracil—colon cancer	0.00291	0.00296	CcSEcCtD
Ranolazine—Pancytopenia—Methotrexate—colon cancer	0.00291	0.00296	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00289	0.00294	CcSEcCtD
Ranolazine—Mental disorder—Capecitabine—colon cancer	0.00289	0.00293	CcSEcCtD
Ranolazine—Feeling abnormal—Irinotecan—colon cancer	0.00288	0.00293	CcSEcCtD
Ranolazine—Malnutrition—Capecitabine—colon cancer	0.00287	0.00291	CcSEcCtD
Ranolazine—Dysuria—Methotrexate—colon cancer	0.00287	0.00291	CcSEcCtD
Ranolazine—Gastrointestinal pain—Irinotecan—colon cancer	0.00286	0.00291	CcSEcCtD
Ranolazine—Abdominal pain—Vincristine—colon cancer	0.00284	0.00288	CcSEcCtD
Ranolazine—Flatulence—Capecitabine—colon cancer	0.00283	0.00287	CcSEcCtD
Ranolazine—Erectile dysfunction—Methotrexate—colon cancer	0.00282	0.00287	CcSEcCtD
Ranolazine—Abdominal pain—Irinotecan—colon cancer	0.00277	0.00281	CcSEcCtD
Ranolazine—Feeling abnormal—Fluorouracil—colon cancer	0.00276	0.0028	CcSEcCtD
Ranolazine—Muscle spasms—Capecitabine—colon cancer	0.00276	0.0028	CcSEcCtD
Ranolazine—Vision blurred—Capecitabine—colon cancer	0.0027	0.00275	CcSEcCtD
Ranolazine—Tremor—Capecitabine—colon cancer	0.00269	0.00273	CcSEcCtD
Ranolazine—Renal failure—Methotrexate—colon cancer	0.00269	0.00273	CcSEcCtD
Ranolazine—Carvedilol—ABCB1—colon cancer	0.00268	0.177	CrCbGaD
Ranolazine—Urticaria—Fluorouracil—colon cancer	0.00266	0.0027	CcSEcCtD
Ranolazine—Haematuria—Methotrexate—colon cancer	0.00261	0.00265	CcSEcCtD
Ranolazine—Epistaxis—Methotrexate—colon cancer	0.00258	0.00262	CcSEcCtD
Ranolazine—Vertigo—Capecitabine—colon cancer	0.00258	0.00262	CcSEcCtD
Ranolazine—Asthenia—Vincristine—colon cancer	0.00258	0.00262	CcSEcCtD
Ranolazine—Syncope—Capecitabine—colon cancer	0.00257	0.00261	CcSEcCtD
Ranolazine—Leukopenia—Capecitabine—colon cancer	0.00257	0.00261	CcSEcCtD
Ranolazine—Palpitations—Capecitabine—colon cancer	0.00254	0.00258	CcSEcCtD
Ranolazine—Loss of consciousness—Capecitabine—colon cancer	0.00252	0.00256	CcSEcCtD
Ranolazine—Asthenia—Irinotecan—colon cancer	0.00251	0.00255	CcSEcCtD
Ranolazine—Cough—Capecitabine—colon cancer	0.0025	0.00254	CcSEcCtD
Ranolazine—Anxiety—Capecitabine—colon cancer	0.00244	0.00247	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00243	0.00246	CcSEcCtD
Ranolazine—Urinary tract disorder—Methotrexate—colon cancer	0.00242	0.00246	CcSEcCtD
Ranolazine—Urethral disorder—Methotrexate—colon cancer	0.00241	0.00244	CcSEcCtD
Ranolazine—Dry mouth—Capecitabine—colon cancer	0.00239	0.00243	CcSEcCtD
Ranolazine—Dizziness—Vincristine—colon cancer	0.00238	0.00241	CcSEcCtD
Ranolazine—Pruritus—Fluorouracil—colon cancer	0.00237	0.00241	CcSEcCtD
Ranolazine—Visual impairment—Methotrexate—colon cancer	0.00237	0.0024	CcSEcCtD
Ranolazine—Confusional state—Capecitabine—colon cancer	0.00236	0.0024	CcSEcCtD
Ranolazine—Dizziness—Irinotecan—colon cancer	0.00231	0.00235	CcSEcCtD
Ranolazine—Shock—Capecitabine—colon cancer	0.0023	0.00234	CcSEcCtD
Ranolazine—Nervous system disorder—Capecitabine—colon cancer	0.0023	0.00233	CcSEcCtD
Ranolazine—Eye disorder—Methotrexate—colon cancer	0.00229	0.00233	CcSEcCtD
Ranolazine—Thrombocytopenia—Capecitabine—colon cancer	0.00229	0.00233	CcSEcCtD
Ranolazine—Tinnitus—Methotrexate—colon cancer	0.00229	0.00232	CcSEcCtD
Ranolazine—Vomiting—Vincristine—colon cancer	0.00228	0.00232	CcSEcCtD
Ranolazine—Cardiac disorder—Methotrexate—colon cancer	0.00228	0.00231	CcSEcCtD
Ranolazine—Skin disorder—Capecitabine—colon cancer	0.00228	0.00231	CcSEcCtD
Ranolazine—Rash—Vincristine—colon cancer	0.00227	0.0023	CcSEcCtD
Ranolazine—Hyperhidrosis—Capecitabine—colon cancer	0.00226	0.0023	CcSEcCtD
Ranolazine—Dermatitis—Vincristine—colon cancer	0.00226	0.0023	CcSEcCtD
Ranolazine—Headache—Vincristine—colon cancer	0.00225	0.00229	CcSEcCtD
Ranolazine—Anorexia—Capecitabine—colon cancer	0.00223	0.00227	CcSEcCtD
Ranolazine—Angiopathy—Methotrexate—colon cancer	0.00223	0.00226	CcSEcCtD
Ranolazine—Vomiting—Irinotecan—colon cancer	0.00223	0.00226	CcSEcCtD
Ranolazine—Dizziness—Fluorouracil—colon cancer	0.00222	0.00225	CcSEcCtD
Ranolazine—Mediastinal disorder—Methotrexate—colon cancer	0.00221	0.00225	CcSEcCtD
Ranolazine—Rash—Irinotecan—colon cancer	0.00221	0.00224	CcSEcCtD
Ranolazine—Dermatitis—Irinotecan—colon cancer	0.0022	0.00224	CcSEcCtD
Ranolazine—Headache—Irinotecan—colon cancer	0.00219	0.00223	CcSEcCtD
Ranolazine—Hypotension—Capecitabine—colon cancer	0.00219	0.00222	CcSEcCtD
Ranolazine—Mental disorder—Methotrexate—colon cancer	0.00215	0.00218	CcSEcCtD
Ranolazine—Malnutrition—Methotrexate—colon cancer	0.00214	0.00217	CcSEcCtD
Ranolazine—Nausea—Vincristine—colon cancer	0.00213	0.00217	CcSEcCtD
Ranolazine—Vomiting—Fluorouracil—colon cancer	0.00213	0.00216	CcSEcCtD
Ranolazine—Insomnia—Capecitabine—colon cancer	0.00212	0.00215	CcSEcCtD
Ranolazine—Rash—Fluorouracil—colon cancer	0.00211	0.00215	CcSEcCtD
Ranolazine—Dermatitis—Fluorouracil—colon cancer	0.00211	0.00214	CcSEcCtD
Ranolazine—Paraesthesia—Capecitabine—colon cancer	0.0021	0.00214	CcSEcCtD
Ranolazine—Headache—Fluorouracil—colon cancer	0.0021	0.00213	CcSEcCtD
Ranolazine—Dyspnoea—Capecitabine—colon cancer	0.00209	0.00212	CcSEcCtD
Ranolazine—Nausea—Irinotecan—colon cancer	0.00208	0.00211	CcSEcCtD
Ranolazine—Dyspepsia—Capecitabine—colon cancer	0.00206	0.00209	CcSEcCtD
Ranolazine—Propranolol—ABCB1—colon cancer	0.00204	0.134	CrCbGaD
Ranolazine—Decreased appetite—Capecitabine—colon cancer	0.00204	0.00207	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00202	0.00205	CcSEcCtD
Ranolazine—Fatigue—Capecitabine—colon cancer	0.00202	0.00205	CcSEcCtD
Ranolazine—Vision blurred—Methotrexate—colon cancer	0.00201	0.00204	CcSEcCtD
Ranolazine—Constipation—Capecitabine—colon cancer	0.002	0.00203	CcSEcCtD
Ranolazine—Nausea—Fluorouracil—colon cancer	0.00199	0.00202	CcSEcCtD
Ranolazine—Feeling abnormal—Capecitabine—colon cancer	0.00193	0.00196	CcSEcCtD
Ranolazine—Vertigo—Methotrexate—colon cancer	0.00192	0.00195	CcSEcCtD
Ranolazine—Gastrointestinal pain—Capecitabine—colon cancer	0.00192	0.00194	CcSEcCtD
Ranolazine—Leukopenia—Methotrexate—colon cancer	0.00191	0.00194	CcSEcCtD
Ranolazine—Cough—Methotrexate—colon cancer	0.00186	0.00189	CcSEcCtD
Ranolazine—Urticaria—Capecitabine—colon cancer	0.00186	0.00189	CcSEcCtD
Ranolazine—Abdominal pain—Capecitabine—colon cancer	0.00185	0.00188	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00181	0.00183	CcSEcCtD
Ranolazine—Confusional state—Methotrexate—colon cancer	0.00176	0.00179	CcSEcCtD
Ranolazine—Nervous system disorder—Methotrexate—colon cancer	0.00171	0.00174	CcSEcCtD
Ranolazine—Thrombocytopenia—Methotrexate—colon cancer	0.00171	0.00173	CcSEcCtD
Ranolazine—Skin disorder—Methotrexate—colon cancer	0.00169	0.00172	CcSEcCtD
Ranolazine—Hyperhidrosis—Methotrexate—colon cancer	0.00169	0.00171	CcSEcCtD
Ranolazine—Asthenia—Capecitabine—colon cancer	0.00168	0.00171	CcSEcCtD
Ranolazine—Anorexia—Methotrexate—colon cancer	0.00166	0.00169	CcSEcCtD
Ranolazine—Pruritus—Capecitabine—colon cancer	0.00166	0.00168	CcSEcCtD
Ranolazine—Hypotension—Methotrexate—colon cancer	0.00163	0.00165	CcSEcCtD
Ranolazine—Insomnia—Methotrexate—colon cancer	0.00158	0.0016	CcSEcCtD
Ranolazine—Paraesthesia—Methotrexate—colon cancer	0.00157	0.00159	CcSEcCtD
Ranolazine—Dyspnoea—Methotrexate—colon cancer	0.00155	0.00158	CcSEcCtD
Ranolazine—Somnolence—Methotrexate—colon cancer	0.00155	0.00157	CcSEcCtD
Ranolazine—Dizziness—Capecitabine—colon cancer	0.00155	0.00157	CcSEcCtD
Ranolazine—Dyspepsia—Methotrexate—colon cancer	0.00153	0.00156	CcSEcCtD
Ranolazine—Decreased appetite—Methotrexate—colon cancer	0.00152	0.00154	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00151	0.00153	CcSEcCtD
Ranolazine—Fatigue—Methotrexate—colon cancer	0.0015	0.00153	CcSEcCtD
Ranolazine—Vomiting—Capecitabine—colon cancer	0.00149	0.00151	CcSEcCtD
Ranolazine—Rash—Capecitabine—colon cancer	0.00148	0.0015	CcSEcCtD
Ranolazine—Dermatitis—Capecitabine—colon cancer	0.00148	0.0015	CcSEcCtD
Ranolazine—Headache—Capecitabine—colon cancer	0.00147	0.00149	CcSEcCtD
Ranolazine—Feeling abnormal—Methotrexate—colon cancer	0.00144	0.00146	CcSEcCtD
Ranolazine—Gastrointestinal pain—Methotrexate—colon cancer	0.00143	0.00145	CcSEcCtD
Ranolazine—Nausea—Capecitabine—colon cancer	0.00139	0.00141	CcSEcCtD
Ranolazine—Urticaria—Methotrexate—colon cancer	0.00139	0.00141	CcSEcCtD
Ranolazine—Abdominal pain—Methotrexate—colon cancer	0.00138	0.0014	CcSEcCtD
Ranolazine—Asthenia—Methotrexate—colon cancer	0.00125	0.00127	CcSEcCtD
Ranolazine—Pruritus—Methotrexate—colon cancer	0.00123	0.00125	CcSEcCtD
Ranolazine—Dizziness—Methotrexate—colon cancer	0.00115	0.00117	CcSEcCtD
Ranolazine—Vomiting—Methotrexate—colon cancer	0.00111	0.00113	CcSEcCtD
Ranolazine—Rash—Methotrexate—colon cancer	0.0011	0.00112	CcSEcCtD
Ranolazine—Dermatitis—Methotrexate—colon cancer	0.0011	0.00112	CcSEcCtD
Ranolazine—Headache—Methotrexate—colon cancer	0.00109	0.00111	CcSEcCtD
Ranolazine—Nausea—Methotrexate—colon cancer	0.00104	0.00105	CcSEcCtD
